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LETTERS TO THE EDITOR
InVivo Studies of Mutant Keratin 1 in Ichthyosis Hystrix
Curth^Macklin
To the Editor:
Keratin 1 (K1) is one of the major keratins expressed in di¡eren-
tiating epidermal keratinocytes. Pathogenic mutations in the K1
gene, KRT1, have been demonstrated to underlie several distinct
disorders of keratinization, such as epidermolytic hyperkeratosis
(bullous congenital ichthyosiform erythroderma) and nonepider-
molytic, di¡use palmoplantar keratoderma (PPK) (for review
see Ishida-Yamamoto et al, 2002). Recently, we have identi¢ed
a heterozygous frameshift mutation in KRT1 (1609^1610delGGin-
sA) in a multigenerational family with ichthyosis hystrix
Curth^Macklin (IHCM, OMIM 146590) (Sprecher et al, 2001).
IHCM is a rare autosomal dominant skin disorder characterized
by extensive (nonepidermolytic) hyperkeratosis that involves
in some families (Ollendor¡ Curth and Macklin, 1954; Sprecher
et al, 2001) predominantly palms and soles, although skin over
large joints and the trunk may also be a¡ected. The
hyperkeratosis may initially show a striate pattern but often is
di¡use, leading to severe £exural contractures, ¢ssures, and
sometimes loss of digits. IHCM is characterized by speci¢c
ultrastructural abnormalities of the cytoskeleton of suprabasal
keratinocytes, including an entangled meshwork of individual
keratin intermediate ¢laments (KIF), which aggregate in cyto-
plasmic shells instead of forming KIF bundles, perinuclear
vacuolization, and the presence of binucleated cells (Anton-
Lamprecht et al, 1973; Niemi et al, 1990; Anton-Lamprecht, 1994;
Sprecher et al, 2001). The mutation 1609^1610delGGinsA, which
occurred in a region encoding the variable tail domain (V2) of
K1, was shown to replace most of the wild-type carboxy-terminal
sequence, including the structurally and functionally important
glycine loop motifs of K1, with an aberrant and truncated peptide
of 76 residues.
Interestingly, another heterozygous frameshift mutation in
KRT1 (1628delG) at almost the same location was detected in a
family with autosomal dominant striate palmoplantar keratoder-
ma (SPPK, OMIM 148700) (Whittock et al, 2002). The predicted
molecular consequences of this single nucleotide deletion were
comparable with those observed in IHCM, including replace-
ment of the carboxy-terminal glycine-rich V2 tail with a novel,
alanine-rich and shorter peptide. Nonetheless, clinical features
and underlying ultrastructural abnormalities di¡ered. The hyper-
keratosis in SPPK was distributed in a linear or plaque-like pat-
tern, was limited to palms and soles, and much less severe than in
IHCM. Electron microscopy revealed only slightly decreased
electron density of KIF but attenuation of desmosomal midline
structures as well as the outer desmosomal plaques where KIF
are inserted (Whittock et al, 2002). These features broadly overlap
with those observed in SPPK due to mutations in genes encoding
the major desmosomal proteins, desmoplakin and desmoglein 1,
which presumably led to haploinsu⁄ciency of the faulty proteins
(Armstrong et al, 1999; Rickman et al, 1999;Whittock et al, 1999;
Hunt et al, 2001).
To investigate possible pathomechanisms for either KRT1 mu-
tation,Whittock et al (2002) performed in vitro transfections with
four mutant K1(mK1)-GFP constructs, including the mutants
causing IHCM and SPPK. In contrast to wild-type K1 (wtK1)
with typical ¢lamentous, cytoplasmic distribution, all tested mu-
tants showed partial nuclear localization, although their newly
gained V2 sequences did not contain potential nuclear localiza-
tion signals. As a similar faulty K1 distribution was also observed
for K1 variants truncated before or within the V2 domain, it was
proposed that nuclear accumulation of mK1-GFP is attributable
to the loss of the wild-type V2 tail domain.
To evaluate the biologic relevance of these observations in vivo,
we assessed in this study the distribution pattern of mK1 as well
as the desmosomal ultrastructure in skin samples of a patient with
IHCM by immunohistochemistry and immunoelectron micro-
scopy. We raised a polyclonal rabbit antibody (mK1) against a
peptide of 14 amino acids corresponding to the carboxy-terminal
end of mK1 anchored by a cysteine (C/LAAGALAAGALEAP)
(Ishida-Yamamoto et al, 2000). Corni¢ed cells obtained from skin
scrapings of an a¡ected individual with IHCM carrying mutation
1609^1610delGGinsA (Sprecher et al, 2001) and an una¡ected con-
trol individual were processed for immunoblotting (Ishida-Yama-
moto et al, 2000). A speci¢c band of 60 kDa corresponding to the
mK1 polypeptide, which is 32 amino acids shorter than wtK1
(molecular weight 65494), was detected in the patient sample
but not in the control (Fig 1a). Immunohistochemistry was
performed on a skin biopsy sample of hyperkeratotic sole skin
(Fig 1b^e). In contrast to control skin, mK1 staining was
observed from just above the basal cells throughout all layers of
the epidermis, including the stratum corneum. Immuno£uores-
cence analysis revealed extensive colocalization of wtK1 and
mK1 in the cytoplasm, but neither protein was detected within
the nuclei (Fig 1e). Using antibodies against mK1, wtK1, and des-
moglein 1 for immunoelectron microscopy, we con¢rmed the
coexpression of mK1 and wtK1 polypeptides in cytoplasmic
KIF (Fig 1f) and association of mK1-positive KIF with the
desmosomal plaques (Fig 1h), whereas again no nuclear accumu-
lation of mK1was observed (Fig 1i). The mK1 and wtK1 positive
KIF network appeared abnormal and not bundled (Fig 1f,h,i),
di¡ering from thick bundles (tono¢brils) labeled only with
wtK1 in the normal control skin (Fig 1g). KIF in the basal
cells of the patient were normal. In contrast to SPPK, the
ultrastructure of desmosomal plaques as well as the expression
of desmoglein 1 and desmoplakin did not reveal any abnorma-
lities in IHCM (Fig 2). Speci¢cally, inner plaques and midlines
of desmosomes in keratinocytes expressing mK1 were
well developed and indistinguishable from a normal control
(Fig 2i,j).
This study, together with the detection of mK1 by MALDI-
TOF mass spectroscopy (Sprecher et al, 2001), unequivocally de-
monstrate that the predicted mK1 allele leading to IHCM is in-
deed expressed in vivo and not subjected to non-sense-mediated
mRNA decay (Frischmeyer and Dietz, 1999). The broad colocali-
zation of mK1 and wtK1 also indicates a normal site- and di¡er-
entiation-speci¢c expression pro¢le of mK1. Considering the
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abnormal organization of KIF that contain mK1 and their
accumulation in shell-like cytoplasmic structures, our observa-
tions strongly suggest that this K1 mutant interferes with
KIF bundling, possibly in a dominant negative fashion, thus
perturbing the KIF cytoskeleton. Our results, however, do not
con¢rm the previously reported in vitro data showing nuclear
localization of mK1-GFP (Whittock et al, 2002). The speci¢c
mechanisms leading to trapping and accumulation of
mK1-GFP in the nuclei remain unclear. There has been no
report showing nuclear localization of keratin proteins in vivo.
Although the wtK1 construct distributed normally in the
transfected cells, the coupled GFP may additionally impair
the distribution of mK1 and may therefore lead to the
abnormal nuclear localization. Alternatively, a disproportional
high expression of K1 constructs could cause aberrant keratin
localization. In either case, our data suggest that nuclear keratins
do not to play an important part for the disease pathology in the
a¡ected skin tissue.
Finally, normal desmosome formation in IHCM suggests
that the cytopathologic e¡ects leading to hyperkeratosis and
PPK in this disorder di¡er from those in SPPK, and may be
related to abnormalities in supramolecular KIF organization
and cytoplasmic tra⁄cking of insoluble proteins, such as
loricrin, as previously suggested (Sprecher et al, 2001). It is
also possible that mK1 impacts upon shapes of the cells and
integrity of other cellular structures, such as organelles and the
nucleus, as the cells are often binucleated and the granular
cells are not £attened (Anton-Lamprecht et al, 1973; Niemi
et al, 1990; Anton-Lamprecht, 1994; Sprecher et al, 2001).
This may lead to gross alteration in the overall structures of the
epidermis.
The reasons for the apparent clinical and ultrastructural di¡er-
ences between IHCM and SPPK despite the similarities of the
mK1 products in both disorders are not clear at present. Possible
explanations could be slight di¡erences in the length of the ab-
normal tail domains, expression of other type II keratins that
might compensate for abnormal K1 functions, or local factors,
such as traumatization due to body weight or manual labor.
Future studies of additional families with di¡erent mutations
in keratin tail domains or transgenic animals expressing this type
Figure1. Detection of mK1 in IHCM. (a) Immunoblot analysis (upper panel). Stratum corneum lysates of the patient (P), and a normal control (C) were
loaded, fractionated on 8% sodium dodecyl sulfate^polyacrylamide gels and immunoblotted with mK1, mK1 preincubated with 1 mM mK1 peptide
(þ peptide) or preimmune serum (pre) (Ishida-Yamamoto et al, 2000). The sizes of molecular weight standards are shown on the left. The arrow denotes the
approximately 60 kDa mK1 protein. Protein staining with Ponceau S (Nacalai Tesque, Kyoto, Japan) of the same membrane is shown in the lower panel.
(b) mK1 immunostaining in lesional plantar skin. Immunogold silver enhancement technique using a section of a Lowicryl K11M resin embedded sample
(Ishida-Yamamoto et al, 1996). Lines mark basement membranes. (c^e) Cryo-ultramicrotome sections of lesional skin (Masunaga et al, 1996) were stained with
mK1 visualized with a secondary antibody coupled to Alexa Fluor 488 (Molecular Probes, Eugene, OR) (green), and a wtK1 antibody (34betaB4, Enzo
Diagnostics, NewYork, NY), visualized with a secondary antibody coupled to Cy3 (Amersham Biosciences, Piscataway, NJ) (red). (c,d) Overlaid on a ¢gure
of DNA staining with DAPI (Nacalai Tesque, Kyoto, Japan) (blue) shown in (e). Digital images were captured using a cooled CCD camera. (f^i) Postembed-
ding immunoelectron microscopy (Ishida-Yamamoto et al, 1996; Ishida-Yamamoto et al, 2000; Sprecher et al, 2001). (f,g) Double staining of mK1 (visualized
with secondary antibody conjugated with 5 nm gold particles) and wtK1 (34betaB4, 10 nm gold particles) of the patient skin (f) and normal control subject
(g). (h) Double staining of mK1 (5 nm gold particles) and desmoglein 1 (Dsg1-P23, Progen, Heidelberg, Germany, 10 nm gold particles). (i) A nucleus (Nu) is
negative to mK1, whereas a shell-like structure surrounding it is positive (10 nm gold particles). Scale bars: (b) 0.1 mm; (e) 0.01 mm; (f^i) 100 nm.
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of mutations might help to clarify and understand these ques-
tions further.
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Figure 2. Desmosomes in IHCM. Cryo-ultramicrotome sections were stained with antibodies against desmoglein 1 (a,b: Dsg1-P23) and desmoplakin (c,d:
desmoplakin multiepitope cocktail, American Research Products, Belmont, MA), and detected with secondary antibodies coupled to £uorescein isothiocya-
nate (DAKO, Glostrup, Denmark). Postembedding immunoelectron microscopy of desmoglein 1 (e,g) and cryo-ultramicrotomy staining of desmoplakin.
(f,h) Ten nanometer gold-conjugated secondary antibodies were used. (i,j) Transmission electron microscopy pictures of desmosomes in the super¢cial epi-
dermis (Sprecher et al, 2001). Inner plaques and midlines of desmosomes are marked with arrowheads and arrows, respectively. Patient skin (a,c,e,f,i) and normal
sole skin (b,d,g,h,j). Scale bars: (a^d) 0.01 mm; (e^j) 100 nm.
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